3.74% -0.7732

Tyra Biosciences Inc (TYRA)

Tyra Biosciences Inc Borsa (TYRA) Ultime notizie

Tyra Biosciences Inc (TYRA)

Tyra Biosciences Inc Borsa (TYRA) Ultime notizie

Tyra Biosciences (NASDAQ:TYRA) Shares Gap Up to $20.55 - MarketBeat

How To Trade (TYRA) - Stock Traders Daily

Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference - Citizentribune

Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 5.7% - MarketBeat

Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference - Quantisnow

Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer - Citizentribune

Tyra Biosciences names Doug Warner as new Chief Medical Officer - Investing.com

Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer - StockTitan

Wall Street Analysts Think Tyra Biosciences (TYRA) Could Surge 27.88%: Read This Before Placing a Bet - Yahoo Finance

Tyra Biosciences (NASDAQ:TYRA) Trading 3.2% Higher - MarketBeat

Tyra Biosciences Inc (TYRA) Stock: Uncovering 52-Week Market Trends - The InvestChronicle

Tyra Biosciences Inc Stockholders Can Partake In An Inquiry Into Whether The Company Defrauded The Public - StockTitan

TYRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Shareholders to Contact the Firm Today! - AccessWire

Tyra Biosciences, Inc. (TYRA): One of Oppenheimer’s Top Stock Picks For the Next 12 Months - Insider Monkey

Tyra Biosciences, Inc. (TYRA): One of Oppenheimer’s Top Stock Picks For the Next 12 Months - Yahoo Finance

An Inquiry Has Been Opened Into Tyra Biosciences Inc’s Possible Securities Related Impropriety And Impacted Stakeholders Should Join - StockTitan

Oppenheimer’s Favorite Stocks For Next 12 Months: Top 32 Stock Picks - Insider Monkey

Non-muscle Invasive Bladder Cancer Pipeline Drugs 2024 | - openPR

The Globe and Mail - The Globe and Mail

TYRA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Investors to Contact the Firm Today! - AccessWire

TYRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Investors to Contact the Firm Today! - AccessWire

Tyra Biosciences (NASDAQ:TYRA) Sees Unusually-High Trading Volume - Defense World

Tyra Biosciences (NASDAQ:TYRA) Sees Large Volume Increase - MarketBeat

TYRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Stockholders to Contact the Firm! - AccessWire

Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 2.3% - Defense World

TYRA Investors Have Opportunity to Join Tyra Biosciences, Inc. Securities Fraud Investigation with the Schall Law Firm - Marketscreener.com

TYRA Investors Have Opportunity to Join Tyra Biosciences, Inc. Securities Fraud Investigation with the Schall Law Firm - Business Wire

Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 2.3% - MarketBeat

TYRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Shareholders to Contact the Firm! - AccessWire

TYRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Shareholders to Contact the Firm! - AccessWire

Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month High at $23.96 - Defense World

Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month High at $23.96 - MarketBeat

Piper Sandler Begins Coverage on Tyra Biosciences (NASDAQ:TYRA) - MarketBeat

Tyra Biosciences stock soars to 52-week high of $23.95 By Investing.com - Investing.com Canada

Tyra Biosciences stock soars to 52-week high of $23.95 By Investing.com - Investing.com Australia

Tyra Biosciences stock could soar as lead drug shows promisePiper Sandler - Investing.com Canada

Tyra Biosciences a new overweight at Piper Sandler as 'next gen FGFR company' - Seeking Alpha

Tyra Biosciences (NASDAQ:TYRA) Coverage Initiated by Analysts at Piper Sandler - Defense World

TYRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Investors to Contact the Firm! - AccessWire

Tyra Biosciences stock could soar as lead drug shows promisePiper Sandler - Investing.com UK

Tyra Biosciences stock soars to 52-week high of $23.95 - Investing.com India

TYRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Investors to Contact the Firm! - AccessWire

Tyra Biosciences (NASDAQ:TYRA) Trading 7.1% Higher - MarketBeat

Tyra Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 - Marketscreener.com

Tyra Biosciences, Inc. (NASDAQ:TYRA) Stake Boosted by Vanguard Group Inc. - Defense World

Vanguard Group Inc. Raises Stock Holdings in Tyra Biosciences, Inc. (NASDAQ:TYRA) - MarketBeat

Tyra Biosciences Reports Second Quarter 2024 Financial Results and Highlights - Marketscreener.com

Analysts Set Expectations for Tyra Biosciences, Inc.’s Q3 2024 Earnings (NASDAQ:TYRA) - Defense World

Q3 2024 EPS Estimates for Tyra Biosciences, Inc. (NASDAQ:TYRA) Raised by Analyst - MarketBeat

Tyra Biosciences (NASDAQ:TYRA) Rating Reiterated by Wedbush - Defense World

Tyra Biosciences (NASDAQ:TYRA) Announces Quarterly Earnings Results, Beats Estimates By $0.09 EPS - Defense World

Tyra Biosciences (NASDAQ:TYRA) Releases Quarterly Earnings Results, Beats Estimates By $0.09 EPS - MarketBeat

Tyra Biosciences (NASDAQ:TYRA) Earns Outperform Rating from Wedbush - MarketBeat

Oppenheimer Lowers Tyra Biosciences (NASDAQ:TYRA) Price Target to $25.00 - MarketBeat

Oppenheimer Lowers Tyra Biosciences (NASDAQ:TYRA) Price Target to $25.00 - Defense World

Tyra Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com

Tyra Biosciences Reports Second Quarter 2024 Financial Results and Highlights - StockTitan

Tyra Biosciences Reports Second Quarter 2024 Financial Results and Highlights - PR Newswire

When the Price of (TYRA) Talks, People Listen - Stock Traders Daily

Tyra Biosciences stock soars to 52-week high of $22.22 By Investing.com - Investing.com Nigeria

Tyra Biosciences stock soars to 52-week high of $22.22 - Investing.com

Tyra Biosciences stock soars to 52-week high of $22.22 By Investing.com - Investing.com Canada

Tyra Biosciences stock soars to 52-week high of $22.22 - Investing.com India

Long Term Trading Analysis for (TYRA) - Stock Traders Daily

Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year High at $22.05 - MarketBeat

Tyra Biosciences hits 52-week high, reaching $21.67 By Investing.com - Investing.com Canada

Tyra Biosciences hits 52-week high, reaching $21.67 By Investing.com - Investing.com

Lots Of Bullish Signals, But No Revenue Or Earnings From Tyra Biosciences (NASDAQ:TYRA) - Seeking Alpha

Simile a TYRA